Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Development of anti-breast cancer PI3K inhibitors based on 7-azaindole derivatives through scaffold hopping: Design, synthesis and in vitro biological evaluation
Chengbin Yang, Mingzhu Lu, Yi Chen, et al.
Bioorganic Chemistry (2021) Vol. 117, pp. 105405-105405
Closed Access | Times Cited: 16

Showing 16 citing articles:

Azaindole derivatives as potential kinase inhibitors and their SARs elucidation
Guoqing Fang, Hongjuan Chen, Zhiyun Cheng, et al.
European Journal of Medicinal Chemistry (2023) Vol. 258, pp. 115621-115621
Closed Access | Times Cited: 10
A comprehensive review on phosphatidylinositol-3-kinase (PI3K) and its inhibitors bearing pyrazole or indazole core for cancer therapy
Inês M. Bastos, Sandra Rebelo, Vera L. M. Silva
Chemico-Biological Interactions (2024) Vol. 398, pp. 111073-111073
Open Access | Times Cited: 3
Synthesis, Molecular Docking, In Vitro and In Vivo Studies of Novel Dimorpholinoquinazoline-Based Potential Inhibitors of PI3K/Akt/mTOR Pathway
Maria V. Zapevalova, Ekaterina S. Shchegravina, Irina P. Fonareva, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10854-10854
Open Access | Times Cited: 16
Based on 2-(difluoromethyl)-1-[4,6-di(4-morpholinyl)-1,3,5-triazin-2-yl]-1H-benzimidazole (ZSTK474), design, synthesis and biological evaluation of novel PI3Kα selective inhibitors
Yu Wang, Yajing Liu, Tingjie Ge, et al.
Bioorganic Chemistry (2022) Vol. 130, pp. 106211-106211
Closed Access | Times Cited: 11
Design, synthesis and in vitro biological evaluation of 2-aminopyridine derivatives as novel PI3Kδ inhibitors for hematological cancer
Chengbin Yang, Yimin Gong, Yunjian Gao, et al.
Bioorganic & Medicinal Chemistry Letters (2023) Vol. 82, pp. 129152-129152
Closed Access | Times Cited: 5
Discovery and identification of a novel PI3K inhibitor with enhanced CDK2 inhibition for the treatment of triple negative breast cancer
Chengbin Yang, Menghui Wang, Yimin Gong, et al.
Bioorganic Chemistry (2023) Vol. 140, pp. 106779-106779
Closed Access | Times Cited: 5
Discovery of N-(2-chloro-5-(3-(pyridin-4-yl)-1H-pyrazolo[3,4-b]pyridin-5-yl)pyridin-3-yl)-4-fluorobenzenesulfonamide (FD274) as a highly potent PI3K/mTOR dual inhibitor for the treatment of acute myeloid leukemia
Chengbin Yang, Yi Chen, Tianze Wu, et al.
European Journal of Medicinal Chemistry (2023) Vol. 258, pp. 115543-115543
Closed Access | Times Cited: 4
Design, synthesis and bioactivity evaluation of selenium-containing PI3Kδ inhibitors
Li Gao, Hongyan Chuai, Mengyan Ma, et al.
Bioorganic Chemistry (2023) Vol. 140, pp. 106815-106815
Closed Access | Times Cited: 2
Current Scenario of Pyridine/Quinoline-Sulfonamide Hybrids with Anticancer Potential (A Review)
Guangbin Dong, Yu Feng, Jeh‐Jeng Wang, et al.
Russian Journal of General Chemistry (2024) Vol. 94, Iss. 4, pp. 989-1005
Closed Access
Current scenario of pyrazole hybrids with anti‐breast cancer therapeutic applications
Mengyu Ma
Archiv der Pharmazie (2024) Vol. 357, Iss. 10
Closed Access
Current Scenario of Sulfonamide Hybrids with Anti-Breast Cancer Therapeutic Applications: I. Sulfonamide-Five-Membered Heterocycle Hybrids
Zhi Xu, Mengyu Ma
Russian Journal of General Chemistry (2024) Vol. 94, Iss. 5, pp. 1191-1206
Closed Access
Recent Progress of Sulfonamide-Indole/Carbazole Hybrids with the Anticancer Potential (A Review)
Ye Wang, Chaoyin Liu, Zhi Xu
Russian Journal of Bioorganic Chemistry (2024) Vol. 50, Iss. 5, pp. 2024-2035
Closed Access
Research progress and development strategy of PI3K inhibitors for breast cancer treatment: A review (2016-present)
Rujue Peng, Yujie Zhan, Anqi Li, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107934-107934
Closed Access
A new herbal extract carbon nanodot nanomedicine for anti-renal cell carcinoma through the PI3K/AKT signaling pathway
Ning Tian, Xiangling Liu, Xiaoyu He, et al.
RSC Advances (2024) Vol. 14, Iss. 49, pp. 36437-36450
Open Access
Synthesis, Characterization and Biological Evaluation of Some Novel Pyrrolopyrimidine Analogues
SANJAY P. TAJANE, Ganapavarapu Veera Raghava Sharma, Sushilkumar A. Dhanmane, et al.
Asian Journal of Chemistry (2023) Vol. 35, Iss. 10, pp. 2549-2553
Open Access | Times Cited: 1
Synthesis, Crystal Structure and DFT Study of 5-Bromo-1-Tosyl-1H-Pyrrolo[2,3-b]Pyridine
Tao Cheng, Jing Jin, Chao Yang, et al.
Journal of Structural Chemistry (2023) Vol. 64, Iss. 8, pp. 1369-1379
Closed Access
Page 1

Scroll to top